Piper Sandler on Oruka Therapeutics (ORKA): 'We remain bullish into a catalyst-rich year+'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: ORKA) | Delayed: 100.55 +1.00 (1.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $99.55 | 52 Week High | $ | |||
| Open | $102.37 | 52 Week Low | $ | |||
| Day High | $102.59 | P/E | N/A | |||
| Day Low | $99.74 | EPS | $ | |||
| Volume | 66,641 | |||||
